• Ocuphire Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 marketscreener.com Mon, 28 Apr 2025 12:50:56 GMT
• prism marketview spotlights opus genetics in new q&a with ceo george magrath Seeking Alpha Tue, 15 Apr 2025 14:36:00 GMT
• Opus Genetics (NASDAQ:IRD) Research Coverage Started at Craig Hallum Defense World Mon, 14 Apr 2025 07:00:00 GMT
• Founder Mina Sooch Issues Open Letter to Opus Genetics Stockholders Following Withdrawal of the Restore Value Slate Amid Dilutive ... The Manila Times Sat, 12 Apr 2025 07:00:00 GMT
• founder mina sooch issues open letter to opus genetics stockholders following withdrawal of the restore value slate amid dilutive ... The Manila Times Fri, 11 Apr 2025 19:58:40 GMT
• Drug company founder pulls plug on proxy fight at her former company Crain's Detroit Business Fri, 11 Apr 2025 07:00:00 GMT
• Night Vision Disturbances Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Ocuphire Pharma, Viatris The Globe and Mail Thu, 10 Apr 2025 07:00:00 GMT
• opus genetics eyes 2026 start for pivotal trial of gene therapy for rare retinal disease Precision Medicine Online Thu, 10 Apr 2025 07:00:00 GMT
• opus genetics says mina sooch determined to withdraw her slate of nominees for election to board MarketScreener Wed, 09 Apr 2025 21:45:18 GMT
• mydriasis market predicted to see upsurge through 2034, highlights delveinsight | viatris/ocuphire pharma, eyenovia, rayner surgic... Barchart.com Wed, 09 Apr 2025 14:56:00 GMT
• opus genetics gets fda fast track designation for phentolamine ophthalmic solution MSN Wed, 09 Apr 2025 09:40:19 GMT
• Opus Genetics celebrates early win for retinal gene therapy in teen patient FirstWord Pharma Tue, 08 Apr 2025 07:00:00 GMT
• Opus Genetics' Future at Stake: Ex-CEO Challenges $21.5M-Backed Gene Therapy Transformation Stock Titan Mon, 07 Apr 2025 07:00:00 GMT
• Opus Genetics Files Definitive Proxy Statement and Sends GlobeNewswire Mon, 07 Apr 2025 07:00:00 GMT
• Opus Genetics (NASDAQ:IRD) Price Target Cut to $8.00 by Analysts at Jones Trading Defense World Wed, 02 Apr 2025 07:00:00 GMT
• opus genetics (nasdaq:ird) receives buy rating from hc wainwright Defense World Wed, 02 Apr 2025 07:00:00 GMT
• Ousted founder of drug development company tries to take back the reins Crain's Detroit Business Fri, 28 Mar 2025 07:00:00 GMT
• critical contrast: mersana therapeutics (nasdaq:mrsn) & opus genetics (nasdaq:ird) Defense World Fri, 28 Mar 2025 07:00:00 GMT
• opus genetics closes $20m offering, issues private placement by investing.com Investing.com India Tue, 25 Mar 2025 07:00:00 GMT
• Opus Genetics closes $20M offering, issues private placement Investing.com Mon, 24 Mar 2025 07:00:00 GMT
• Restore Value Slate Led by Mina Sooch Files Preliminary Proxy Materials for the Election of Six Highly Qualified Directors at the ... The Manila Times Sat, 22 Mar 2025 07:00:00 GMT
• opus genetics prices public offering, private placement -march 21, 2025 at 09:33 am edt MarketScreener Fri, 21 Mar 2025 13:39:52 GMT
• restore value slate led by mina sooch files preliminary proxy materials for the election of six highly qualified directors at the ... TradingView Fri, 21 Mar 2025 07:00:00 GMT
• opus genetics founder mina sooch files preliminary proxy materials for co board election MarketScreener Fri, 21 Mar 2025 07:00:00 GMT
• open angle glaucoma market to show remarkable growth trends from 2023 to 2032, delveinsight reports | visiox pharma, tearclear, vi... The Globe and Mail Fri, 21 Mar 2025 07:00:00 GMT
• Opus Genetics enhances shareholder rights, sues for patent infringement Investing.com Thu, 20 Mar 2025 07:00:00 GMT
• diabetic retinopathy clinical trials and studies: ema, pdma, fda approvals, mechanism of action, roa, nda, ind, and companies The Globe and Mail Wed, 12 Mar 2025 17:48:00 GMT
• opus genetics in jan, got paragraph iv certification notice from winston & strawn, counsel to sandoz incorporated Marketscreener.com Tue, 04 Mar 2025 22:07:33 GMT
• opus genetics gets fda fast track designation for phentolamine ophthalmic solution MSN Thu, 27 Feb 2025 12:16:49 GMT
• opus genetics gets fda fast track designation for phentolamine ophthalmic solution MSN Wed, 26 Feb 2025 16:49:04 GMT
• shareholder group nominates slate of director candidates for opus genetics TipRanks Fri, 07 Feb 2025 14:52:48 GMT
• mina sooch nominates slate of director candidates to the board of opus genetics -february 07, 2025 at 09:15 am est Marketscreener.com Fri, 07 Feb 2025 14:15:00 GMT
• shareholder group led by founder mina sooch nominates majority slate of director candidates to the board of opus genetics, inc. TradingView Fri, 07 Feb 2025 08:00:00 GMT
• opus genetics revises executive compensation agreements Investing.com Fri, 24 Jan 2025 08:00:00 GMT
• opus genetics sets april 30 for 2025 annual meeting Investing.com India Fri, 24 Jan 2025 02:57:59 GMT
• opus genetics launches $40m at-the-market equity program by investing.com Investing.com South Africa Tue, 14 Jan 2025 16:13:04 GMT
• mydriasis pipeline 2024: clinical trials assessment, fda approvals, therapies, and key companies involved by delveinsight | viatri... The Globe and Mail Fri, 10 Jan 2025 01:57:24 GMT
• mydriasis pipeline 2024: clinical trials assessment, fda approvals, therapies, and key companies involved by delveinsight | viatri... The Globe and Mail Thu, 09 Jan 2025 08:00:00 GMT
• opus genetics ceo magrath george buys $97,600 in stock Investing.com Mon, 30 Dec 2024 08:00:00 GMT
• opus genetics aligns with fda on phase 3 trial for diabetic retinopathy drug Investing.com Canada Fri, 20 Dec 2024 09:33:53 GMT
• opus genetics aligns with fda on phase 3 trial for diabetic retinopathy drug Investing.com Thu, 19 Dec 2024 13:53:42 GMT
• ird stock touches 52-week low at $0.84 amid market challenges Investing.com Wed, 18 Dec 2024 08:00:00 GMT
• ocuphire pharma sets end-of-phase 2 meeting with fda in q4 to discuss diabetic retinopathy treatment Marketscreener.com Tue, 17 Dec 2024 00:54:37 GMT
• opus genetics, inc. reports earnings results for the fourth quarter and full year ended december 31, 2023 Marketscreener.com Sun, 15 Dec 2024 02:54:47 GMT
• proliferative diabetic retinopathy market forecast: growth drivers and future directions industry overview,... WhaTech Fri, 06 Dec 2024 01:02:05 GMT
• opus genetics, inc. to host virtual kol event on opgx-lca5 as a treatment for lca5-associated inherited retinal disease on decembe... Marketscreener.com Tue, 03 Dec 2024 13:00:00 GMT
• opus genetics president benjamin yerxa acquires $9,834 in stock Investing.com India Tue, 26 Nov 2024 08:00:00 GMT
• opus genetics president benjamin yerxa acquires $9,834 in stock Investing.com Mon, 25 Nov 2024 08:00:00 GMT
• fy2024 eps estimates for opus genetics cut by hc wainwright Defense World Sat, 16 Nov 2024 07:51:38 GMT
• wainwright sets stock target on opus genetics, cites 2025 catalysts Investing.com India Thu, 14 Nov 2024 11:59:20 GMT
• ird stock touches 52-week low at $1.07 amid market challenges Investing.com India Thu, 14 Nov 2024 08:00:00 GMT
• opus genetics, inc. reports earnings results for the second quarter and six months ended june 30, 2024 Marketscreener.com Wed, 13 Nov 2024 14:00:28 GMT
• opus genetics reports $7.5 million net loss in third quarter Vision Monday Wed, 13 Nov 2024 08:00:00 GMT
• wainwright sets stock target on opus genetics, cites 2025 catalysts Investing.com Wed, 13 Nov 2024 08:00:00 GMT
• ird stock touches 52-week low at $1.07 amid market challenges Investing.com Wed, 13 Nov 2024 08:00:00 GMT
• opus genetics announces financial results for third quarter 2024 and provides corporate update GlobeNewswire Tue, 12 Nov 2024 08:00:00 GMT
• The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics PR Newswire Fri, 25 Oct 2024 07:00:00 GMT
• Ocuphire buys Opus Genetics, grows gene therapy pipeline The Pharma Letter Thu, 24 Oct 2024 07:00:00 GMT
• ocuphire pharma announces acquisition of opus genetics VisionMonday.com Thu, 24 Oct 2024 07:00:00 GMT
• north carolina gains public company with merger The Business Journals Thu, 24 Oct 2024 07:00:00 GMT
• ocuphire shares rise after extended us patent for nyxol eye drops secured Marketscreener.com Thu, 24 Oct 2024 03:47:57 GMT
• ocuphire pharma, inc. announces appointments of nirav jhaveri, c.f.a., m.b.a. as chief financial officer Marketscreener.com Thu, 24 Oct 2024 03:00:34 GMT
• ocuphire to transform into gene therapy biotech via opus buyout Fierce Biotech Wed, 23 Oct 2024 09:31:35 GMT
• ocuphire pharma to transform into gene therapy-focused biotech via opus acquisition Fierce Biotech Wed, 23 Oct 2024 09:31:35 GMT
• ocuphire pharma acquires opus genetics in all-stock deal by investing.com Investing.com Australia Wed, 23 Oct 2024 07:59:25 GMT
• Ocuphire Pharma to transform into gene-therapy-focused biotech via Opus acquisition Fierce Biotech Wed, 23 Oct 2024 07:00:00 GMT
• Shareholder Alert: Ademi LLP Investigates Whether Ocuphire Pharma, Inc. Is Breaching Its Duties to Its Public Shareholders Business Wire Wed, 23 Oct 2024 07:00:00 GMT
• Ocuphire and Opus Genetics merge to develop IRD gene therapy Pharmaceutical Technology Wed, 23 Oct 2024 07:00:00 GMT
• Ocuphire pivots to retinal gene therapies with Opus Genetics buy FirstWord Pharma Wed, 23 Oct 2024 07:00:00 GMT
• ocuphire pharma merges with opus genetics, renamed opus genetics Yahoo Finance Wed, 23 Oct 2024 07:00:00 GMT
• ophthalmic biopharmaceutical ocuphire pharma shifts focus to gene therapy through opus genetics stock deal Benzinga Wed, 23 Oct 2024 07:00:00 GMT
• ocup stock touches 52-week low at $1.14 amid market challenges Investing.com Wed, 23 Oct 2024 07:00:00 GMT
• ocuphire pharma price target lowered to $10 from $18 at canaccord TipRanks Wed, 23 Oct 2024 07:00:00 GMT
• wilson sonsini advises opus genetics on ip matters related to acquisition by ocuphire pharma Wilson Sonsini Wed, 23 Oct 2024 01:00:35 GMT
• Ocuphire Pharma Announces Acquisition of Opus Genetics GlobeNewswire Tue, 22 Oct 2024 07:00:00 GMT
• Ocuphire Pharma acquires Opus Genetics in all-stock transaction, to switch name Nasdaq Tue, 22 Oct 2024 07:00:00 GMT
• Eye drop maker to merge with a retinal gene therapy startup from Spark co-founder Endpoints News Tue, 22 Oct 2024 07:00:00 GMT
• wilson sonsini advises opus genetics on ip matters related to acquisition by ocuphire pharma Wilson Sonsini Tue, 22 Oct 2024 07:00:00 GMT
• ocuphire pharma merges with opus genetics, renamed opus genetics TipRanks Tue, 22 Oct 2024 07:00:00 GMT
• ocuphire pharma and opus genetics announce merger Ophthalmology Times Europe Tue, 22 Oct 2024 07:00:00 GMT
• open angle glaucoma market forecasted to surge in coming years, 2023-2032 analysis by delveinsight | visiox pharma, tearclear, viv... Barchart Fri, 18 Oct 2024 13:02:00 GMT
• presbyopia market on track for major expansion by 2034, according to delveinsight | eyenovia, orasis pharma, ocuphire pharma, nova... The Globe and Mail Wed, 16 Oct 2024 07:00:00 GMT
• night vision disturbances market forecasted to surge in coming openPR Fri, 11 Oct 2024 19:55:00 GMT
• mydriasis market forecasted to surge in coming years, 2024-2034 openPR Thu, 10 Oct 2024 19:52:00 GMT
• results released from ocuphire pharma of mira-2 and mira-3 clinical trials for phentolamine ophthalmic solution 0.75% for pharmaco... Optometry Times Fri, 04 Oct 2024 07:00:00 GMT
• ocuphire reports positive phase 3 results for eye treatment ryzumvi Investing.com Tue, 01 Oct 2024 01:44:10 GMT
• ocuphire pharma releases results from mira-2 and mira-3 clinical trials for phentolamine ophthalmic solution 0.75% for pharmacolog... Ophthalmology Times Mon, 30 Sep 2024 14:03:45 GMT
• ocuphire pharma announces publication of phase 3 results of ryzumvi TipRanks Mon, 30 Sep 2024 13:13:34 GMT
• ocuphire reports positive phase 3 results for eye treatment ryzumvi Investing.com Mon, 30 Sep 2024 07:00:00 GMT
• mydriasis treatment market booming worldwide with leading key openPR Wed, 18 Sep 2024 13:23:08 GMT
• ocuphire pharma, inc. (ocup) reports q2 loss, lags revenue estimates MSN Sat, 07 Sep 2024 10:48:42 GMT
• First subjects dosed in phase 3 trial of phentolamine ophthalmic solution for presbyopia Healio Fri, 06 Sep 2024 07:00:00 GMT
• ocuphire pharma commences phase 3 trial for presbyopia treatment Investing.com India Fri, 06 Sep 2024 04:57:52 GMT
• update – ocuphire pharma initiates vega-3 phase 3 trial GlobeNewswire Fri, 06 Sep 2024 00:43:00 GMT
• ocuphire pharma inc [ocup] chief scientific & dev. ofc. makes an insider purchase of 3,500 shares worth 6178.0. Knox Daily Thu, 05 Sep 2024 11:51:05 GMT
• update – ocuphire pharma initiates vega-3 phase 3 trial GlobeNewswire Thu, 05 Sep 2024 07:00:00 GMT
• ocuphire pharma doses first patient in phase 3 vega-3 clinical trial Ophthalmology Times Thu, 05 Sep 2024 07:00:00 GMT
• ocuphire pharma initiates vega-3 phase 3 trial evaluating phentolamine ophthalmic solution 0.75% for presbyopia Yahoo Finance Thu, 05 Sep 2024 07:00:00 GMT
• ocuphire pharma commences phase 3 trial for presbyopia treatment by investing.com Investing.com Australia Thu, 05 Sep 2024 07:00:00 GMT
• ocup stock touches 52-week low at $1.15 amid market challenges Investing.com Thu, 05 Sep 2024 02:38:10 GMT
• ocup stock touches 52-week low at $1.15 amid market challenges Investing.com Canada Wed, 04 Sep 2024 07:00:00 GMT
• there is no way ocuphire pharma inc (ocup) can keep these numbers up SETE News Mon, 02 Sep 2024 13:43:36 GMT
• ocuphire pharma inc (ocup) stock: a year of ups and downs US Post News Mon, 02 Sep 2024 07:00:00 GMT
• ocuphire pharma (nasdaq:ocup) stock quotes, forecast and news summary Benzinga Fri, 23 Aug 2024 22:07:00 GMT
• ocuphire pharma inc’s latest rating changes from various analysts Knox Daily Wed, 21 Aug 2024 20:32:48 GMT
• ocup stock earnings: ocuphire pharma misses eps, misses revenue for q2 2024 MSN Wed, 21 Aug 2024 05:49:48 GMT
• analyst forecasts for ocuphire pharma, inc. (nasdaq:ocup) are surging higher simplywall.st Mon, 19 Aug 2024 07:00:00 GMT
• ocuphire pharma announces 2024 second quarter financial results Vision Monday Mon, 19 Aug 2024 07:00:00 GMT
• ocuphire pharma (stu:r3x1) eps (basic) : €-0.50 (ttm as of jun. 2024) GuruFocus.com Sun, 18 Aug 2024 16:41:52 GMT
• ocuphire pharma (stu:r3x1) ev-to-revenue : -0.39 (as of aug. 18, 2024) GuruFocus.com Sun, 18 Aug 2024 15:53:43 GMT
• ocup (ocuphire pharma) 3-year fcf growth rate : 67.10% (as of jun. 2024) GuruFocus.com Sat, 17 Aug 2024 23:58:46 GMT
• ocup (ocuphire pharma) debt-to-revenue : 0.00 (as of jun. 2024) GuruFocus.com Sat, 17 Aug 2024 21:50:04 GMT
• ocup (ocuphire pharma) 50-day sma : $1.71 (as of aug. 17, 2024) GuruFocus.com Sat, 17 Aug 2024 21:38:04 GMT
• ocup (ocuphire pharma) net income : $-14.11 mil (ttm as of jun. 2024) GuruFocus.com Sat, 17 Aug 2024 21:37:22 GMT
• canaccord genuity group reaffirms buy rating for ocuphire pharma (nasdaq:ocup) Defense World Sat, 17 Aug 2024 07:00:00 GMT
• ocuphire pharma (fra:r3x1) pe ratio (ttm) : at loss (as of aug. 18, 2024) GuruFocus.com Fri, 16 Aug 2024 22:42:51 GMT
• was anything negative for ocuphire pharma inc (ocup) stock last session? US Post News Fri, 16 Aug 2024 13:28:17 GMT
• ocuphire pharma, inc. (nasdaq:ocup) forecasted to post q3 2024 earnings of ($0.30) per share Defense World Fri, 16 Aug 2024 12:30:43 GMT
• ocuphire pharma, inc. (nasdaq:ocup) reported earnings last week and analysts are already upgrading their estimates Yahoo Finance Fri, 16 Aug 2024 07:00:00 GMT
• ocuphire pharma inc’s latest rating changes from various analysts Knox Daily Wed, 14 Aug 2024 21:01:49 GMT
• ocuphire pharma inc (ocup) stock: a year of declines and increases The InvestChronicle Wed, 14 Aug 2024 14:33:09 GMT
• financial health check: examining ocuphire pharma inc (ocup)’s key ratios The Dwinnex Wed, 14 Aug 2024 11:20:56 GMT
• ocuphire shares price target cut, buy rating held on fda approval milestone Investing.com Wed, 14 Aug 2024 07:00:00 GMT
• ocuphire pharma price target lowered to $18 from $20 at h.c. wainwright TipRanks Wed, 14 Aug 2024 07:00:00 GMT
• ocuphire pharma, inc. (ocup) reports q2 loss, lags revenue estimates Yahoo Finance UK Tue, 13 Aug 2024 13:10:04 GMT
• Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update GlobeNewswire Tue, 13 Aug 2024 07:00:00 GMT
• ocup stock touches 52-week low at $1.47 amid market challenges Investing.com Tue, 13 Aug 2024 07:00:00 GMT
• ocuphire pharma, inc. reports earnings results for the second quarter and six months ended june 30, 2024 Marketscreener.com Tue, 13 Aug 2024 07:00:00 GMT
• ocup stock earnings: ocuphire pharma misses eps, misses revenue for q2 2024 InvestorPlace Tue, 13 Aug 2024 07:00:00 GMT
• virtu financial llc takes $36,000 position in ocuphire pharma, inc. (nasdaq:ocup) Defense World Fri, 09 Aug 2024 09:57:05 GMT
• ocuphire pharma to present at two investor conferences in august GlobeNewswire Thu, 08 Aug 2024 07:00:00 GMT
• here's why we're not at all concerned with ocuphire pharma's (nasdaq:ocup) cash burn situation Yahoo Finance Thu, 01 Aug 2024 07:00:00 GMT
• short interest in ocuphire pharma, inc. (nasdaq:ocup) decreases by 15.8% MarketBeat Sun, 28 Jul 2024 07:00:00 GMT
• ocuphire pharma, inc. (nasdaq:ocup) sees significant decline in short interest Defense World Sun, 28 Jul 2024 07:00:00 GMT
• comparing vectura group (otcmkts:vegpf) and ocuphire pharma (nasdaq:ocup) Defense World Wed, 24 Jul 2024 07:40:37 GMT
• APX3330 oral treatment for diabetic retinopathy shows encouraging phase 2 data Healio Wed, 24 Jul 2024 07:00:00 GMT
Ocuphire Pharma Inc(NASDAQ:OCUP) 
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of various eye disorders. The company is headquartered in Farmington Hills, Michigan.
Website: https://www.ocuphire.com/
Founded: 2018
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS